INDV
Indivior
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: INDV
- PE Ratio
As of Jul 24, 2026, the INDV stock has a PE ratio of 20.16. The calculation is based on the latest EPS of $2.01 and the stock price of $40.53 per share. An increase of 4.4% has been observed in the PE ratio compared to its average of 19.3 of the last four quarters.
INDV PE ratio history
The mean historical PE ratio of Indivior over the last two years is 65.17. The current 20.16 P/E ratio is 69% lower than the historical average. Looking back at the last two years, INDV's PE ratio peaked in the Dec 2024 quarter at 248.6, with a price of $12.43 and an EPS of $0.05. The Mar 2026 quarter marked the lowest point at 15.16, with a price of $30.48 and an EPS of $2.01.
Indivior PE ratio by year
Maximum annual decrease: -91.41% in 2025
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 21.36 | -91.41% | $35.88 | $1.68 |
| 2024 | 248.6 | N/A | $12.43 | $0.05 |
| 2023 | N/A | N/A | $15.27 | -$0.92 |
| 2022 | N/A | N/A | N/A | -$0.32 |
| 2021 | N/A | N/A | N/A | $1.41 |
| 2020 | N/A | N/A | N/A | -$1.01 |
Indivior PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 15.16 | -29.03% | $30.48 | $2.01 |
| Dec 2025 | 21.36 | -8.76% | $35.88 | $1.68 |
| Sep 2025 | 23.41 | 35.01% | $24.11 | $1.03 |
| Jun 2025 | 17.34 | N/A | $14.74 | $0.85 |
| Mar 2025 | N/A | N/A | $9.53 | -$0.02 |
| Dec 2024 | 248.6 | N/A | $12.43 | $0.05 |
| Sep 2024 | N/A | N/A | $9.75 | -$0.65 |
| Jun 2024 | N/A | N/A | $16.12 | -$1.79 |
| Mar 2024 | N/A | N/A | $21.42 | -$0.79 |
| Dec 2023 | N/A | N/A | $15.27 | -$0.92 |
| Sep 2023 | N/A | N/A | $23.07 | -$1.63 |
| Jun 2023 | N/A | N/A | $23.8 | -$0.36 |
| Mar 2023 | N/A | N/A | N/A | -$0.3 |
| Dec 2022 | N/A | N/A | N/A | -$0.32 |
| Sep 2022 | N/A | N/A | N/A | N/A |
INDV Price vs fair value
INDV average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of INDV is lower than its 3-year average.
PE comparison
With a price to earnings (P/E) of 20.16, INDV ranks higher than the industry average but lower than the Healthcare sector average. In comparison with the Healthcare sector average of 25.31, Indivior's price to earnings (P/E) is 20% lower.
INDV PE vs peers
INDV's PE ratio stands lower than its peer stocks TEVA and AMRX.
| Stock name | PE ratio | Market cap |
|---|---|---|
| INDV Indivior Plc | 20.16 | $4.94B |
| TEVA Teva Pharmaceutical Industries Ltd | 22.49 | $35.88B |
| AMRX Amneal Pharmaceuticals Inc | 45.95 | $5.72B |
| PRGO PERRIGO Co plc | N/A | $1.4B |
Frequently asked questions
What is Indivior's PE ratio?
INDV stock has a price to earnings ratio of 20.16 as of Jul 24, 2026.
What is the 3-year average PE ratio for Indivior (INDV)?
The average PE ratio for INDV stock over the past 3 years is 65.17.
What is the highest PE ratio for INDV?
The highest quarterly PE ratio in the last two years has been 248.6 and it was in the Dec 2024 quarter.
How does the current PE ratio for INDV compare to its historical average?
INDV's current price to earnings ratio is 69% below its 2-year historical average.
How is INDV's PE ratio calculated (Indivior PE ratio formula)?
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Jul 24, 2026), Indivior's share price is $40.53. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $2.01. Therefore, Indivior's PE ratio for today is 20.16. PE RATIO(20.16) = STOCK PRICE($40.53) / TTM EPS($2.01)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.